信达生物(01801.HK)拟3月26日举行董事会会议批准全年业绩

Core Viewpoint - The company, Sinopharm (01801.HK), has announced that it will hold a board meeting on March 26, 2026, to consider and approve its annual performance for the year ending December 31, 2025, and to discuss the potential distribution of a final dividend, if any [1] Group 1 - The board meeting is scheduled for March 26, 2026 [1] - The meeting will focus on the annual performance for the year ending December 31, 2025 [1] - The company will also consider the proposal for a final dividend distribution [1]